SCOPUS 정보 검색 플랫폼

Volumn 13, Issue 12, 2007, Pages 1942-1943

Rhodococcus equi infection after alemtuzumab therapy for T-cell prolymphocytic leukemia

(7) Meeuse, Jan J a Sprenger, Herman G a Van Assen, Sander a Leduc, Dominique b Daenen, Simon M G J a Arends, Jan P a Van Der Werf, Tjip S a

a UNIVERSITY MEDICAL CENTER GRONINGEN (Netherlands)

b Centre Hospitalier Intercommunal Annemasse Bonneville (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZITHROMYCIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DOXORUBICIN; MOXIFLOXACIN; PREDNISOLONE; RIFAMPICIN; VALACICLOVIR; VANCOMYCIN; VINCRISTINE;

AGED; ANAMNESIS; ANIMAL DISEASE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CASE REPORT; CELLULAR IMMUNITY; CLINICAL EXAMINATION; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG DOSE INCREASE; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; LYMPHOCYTOPENIA; MALE; PROLYMPHOCYTIC LEUKEMIA; RHODOCOCCUS EQUI; THORAX RADIOGRAPHY;

EID: 37049038458 PISSN: 10806040 EISSN: 10806059 Source Type: Journal
DOI: 10.3201/eid1312.061559 Document Type: Article

Times cited : (16)

References (7)

1
- 0031114853
- Rhodococcus equi and Arcanobacterium haemolyticum: Two 'coryneform' bacteria increasingly recognized as agents of human infection
- Linder R. Rhodococcus equi and Arcanobacterium haemolyticum: two 'coryneform' bacteria increasingly recognized as agents of human infection. Emerg Infect Dis. 1997;3:145-53.
- (1997) Emerg Infect Dis , vol.3 , pp. 145-153
- Linder, R.¹

2
- 0030806794
- Epidemiology of Rhodococcus equi infections: A review
- Takai S. Epidemiology of Rhodococcus equi infections: a review. Vet Microbiol. 1997;56:167-76.
- (1997) Vet Microbiol , vol.56 , pp. 167-176
- Takai, S.¹

3
- 0037093821
- Rhodococcus equi: An emerging pathogen
- Weinstock DM, Brown AE. Rhodococcus equi: an emerging pathogen. Clin Infect Dis. 2002;34:1379-85.
- (2002) Clin Infect Dis , vol.34 , pp. 1379-1385
- Weinstock, D.M.¹ Brown, A.E.²

4
- 0042236345
- Mechanism of action and resistance to monoclonal antibody therapy
- Villamor N, Montserrat E, Colomer D. Mechanism of action and resistance to monoclonal antibody therapy. Semin Oncol. 2003;30:424-33.
- (2003) Semin Oncol , vol.30 , pp. 424-433
- Villamor, N.¹ Montserrat, E.² Colomer, D.³

5
- 0035885965
- High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H
- Dearden CE, Matutes E, Cazin B, Tjonnfjord GE, Parreira A, Nomdedeu B, et al. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood. 2001;98:1721-6.
- (2001) Blood , vol.98 , pp. 1721-1726
- Dearden, C.E.¹ Matutes, E.² Cazin, B.³ Tjonnfjord, G.E.⁴ Parreira, A.⁵ Nomdedeu, B.⁶

6
- 33745299246
- Infectious complications associated with alemtuzumab use for lymphoproliferative disorders
- Martin SI, Marty FM, Fiumara K, Treon SP, Gribben JG, Baden LR. Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Clin Infect Dis. 2006;43:16-24.
- (2006) Clin Infect Dis , vol.43 , pp. 16-24
- Martin, S.I.¹ Marty, F.M.² Fiumara, K.³ Treon, S.P.⁴ Gribben, J.G.⁵ Baden, L.R.⁶

7
- 0025967019
- Rhodococcus equi: An animal and human pathogen
- Prescott JF. Rhodococcus equi: an animal and human pathogen. Clin Microbiol Rev. 1991;4:20-34. 1944-1947
- (1991) Clin Microbiol Rev , vol.4
- Prescott, J.F.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.